Medicines Distribution Consents




3990

NEW ZEALAND GAZETTE

No. 168

NZ Sponsor: Schering-Plough Pty Limited.
Manufacturer(s): Schering-Plough Laboratories NV, Heist-op-den-Berg, Belgium.
Schering-Plough Products Inc, Manati Operations, Manati, Puerto Rico.

Product: Topamax Sprinkle.
Active Ingredient(s): Topiramate 15 mg.
Dosage Form: Capsule.

NZ Sponsor: Janssen-Cilag Pty Limited.
Manufacturer(s): McNeil Pharmaceutical (a Div. of OMJ Pharmaceuticals Inc.), Dorado, Puerto Rico.

Product: Topamax Sprinkle.
Active Ingredient(s): Topiramate 25 mg.
Dosage Form: Capsule.

NZ Sponsor: Janssen-Cilag Pty Limited.
Manufacturer(s): McNeil Pharmaceutical (a Div. of OMJ Pharmaceuticals Inc.), Dorado, Puerto Rico.

Product: Topamax Sprinkle.
Active Ingredient(s): Topiramate 50 mg.
Dosage Form: Capsule.

NZ Sponsor: Janssen-Cilag Pty Limited.
Manufacturer(s): McNeil Pharmaceutical (a Div. of OMJ Pharmaceuticals Inc.), Dorado, Puerto Rico.

Product: Uniclar.
Active Ingredient(s): Mometasone furoate monohydrate 51.7 µg/dose equivalent to 50 µg/dose mometasone furoate.
Dosage Form: Nasal spray solution.

NZ Sponsor: Schering-Plough Pty Limited.
Manufacturer(s): Schering-Plough Laboratories NV, Heist-op-den-Berg, Belgium. Schering-Plough Products Inc, Manati Operations, Manati, Puerto Rico.

Dated this 3rd day of November 1999.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go8153

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Amaryl.
Active Ingredient(s): Glimepiride 1 mg.
Dosage Form: Tablet.

NZ Sponsor: Hoechst Marion Roussel (NZ) Limited.
Manufacturer(s): Hoechst Marion Roussel SpA, Scoppito, L’Aquila, Italy.
PharmAction Manufacturing Pty Limited, Laverton North, Victoria, Australia.

Product: Amaryl.
Active Ingredient(s): Glimepiride 2 mg.
Dosage Form: Tablet.

NZ Sponsor: Hoechst Marion Roussel (NZ) Limited.
Manufacturer(s): Hoechst Marion Roussel SpA, Scoppito, L’Aquila, Italy.
PharmAction Manufacturing Pty Limited, Laverton North, Victoria, Australia.

Product: Amaryl.
Active Ingredient(s): Glimepiride 3 mg.
Dosage Form: Tablet.

NZ Sponsor: Hoechst Marion Roussel (NZ) Limited.
Manufacturer(s): Hoechst Marion Roussel SpA, Scoppito, L’Aquila, Italy.
PharmAction Manufacturing Pty Limited, Laverton North, Victoria, Australia.

Product: Amaryl.
Active Ingredient(s): Glimepiride 4 mg.



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 168


NZLII PDF NZ Gazette 1999, No 168





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
3 November 1999
Medicines Act 1981, Changed medicine, Distribution consent, Topiramate, Mometasone furoate
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
3 November 1999
Medicines Act 1981, New medicine, Distribution consent, Glimepiride
  • G. R. Boyd, Chief Advisor, Safety and Regulation